Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Bleach baths with 0.005% hypochlorite help manage atopic dermatitis by affecting skin cells and reducing itchiness.

Smoking may contribute to hair loss in men.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

Testosterone helps human pancreatic cells increase insulin release.

A patch made from human lung fibroblast material helps heal skin wounds effectively, including diabetic ulcers.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The symposium concluded that environmental factors significantly contribute to skin aging.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Matriptase is crucial for keeping epithelial tissues healthy and functioning properly.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The document concludes that there are no effective clinical treatments for hearing loss due to hair cell damage, but research is ongoing.

Scientists created 3D hair-like structures that could help study hair growth and test treatments.

DA-9401 helps protect rat testis from finasteride damage.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.